On the Origins of Hepatitis C Virus NS5B Polymerase Inhibitory Activity Using Machine Learning Approaches

Author(s): Apilak Worachartcheewan, Veda Prachayasittikul, Nuttapat Anuwongcharoen, Watshara Shoombuatong, Virapong Prachayasittikul, Chanin Nantasenamat

Journal Name: Current Topics in Medicinal Chemistry

Volume 15 , Issue 18 , 2015

Become EABM
Become Reviewer

Graphical Abstract:


Inhibition of non-structural protein 5B (NS5B) represents an attractive strategy for the therapeutic treatment of hepatitis C virus (HCV). In this study, machine learning classifiers such as artificial neural network (ANN), support vector machine (SVM), random forest (RF) and decision tree (DT) analyses were used to classify 970 compounds based on their physicochemical properties, including quantum chemical descriptors, constitutional descriptors, functional groups and molecular properties. Good predictive performance was obtained from all classifiers, providing accuracies ranging from 82.47–89.61% for external validation set. SVM was noted as the best classifier, indicated by its highest accuracy of 89.61%. The analyses were performed on data sets stratified by structural scaffolds (nucleoside and non-nucleoside) and bioactivities (active and inactive properties). In addition, a molecular fragment analysis was performed to investigate molecular substructures corresponding to biological activities. Furthermore, common substructures and potential functional groups governing the activities of active and inactive inhibitors were noted for the benefit of rational design and high-throughput screening towards potential HCV NS5B inhibitors.

Keywords: Descriptors, HCV NS5B polymerase inhibitors, Hepatitis C virus, Machine learning method, Molecular fragment analysis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [1814 - 1826]
Pages: 13
DOI: 10.2174/1568026615666150506151303
Price: $65

Article Metrics

PDF: 21
PRC: 1